The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+IL-17+ T Cells in Psoriasis Lesions

Scandinavian Journal of Immunology

Volumn 82, Issue 1, 2015, Pages 84-91

  Dyring Andersen, B ^a,b   Bonefeld, C M ^a   Bzorek, M ^c   Lovendorf M B ^b   Lauritsen, J P H ^a   Skov, L ^b   Geisler, C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NAESTVED HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 22; CALCITRIOL; DERMATOLOGICAL AGENT; IL17A PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ANTIGEN RETRIEVAL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ERYTHEMA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN BIOPSY; SKIN CELL; SKIN INDURATION; T LYMPHOCYTE SUBPOPULATION; VITAMIN D RESPONSIVE ELEMENT; AGED; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PSORIASIS; YOUNG ADULT;

ADULT; AGED; CALCITRIOL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATOLOGIC AGENTS; ERYTHEMA; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PSORIASIS; YOUNG ADULT;

EID: 84930995048     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12304     Document Type: Article

References (42)

1. Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 2013;133:377-85.
2. Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031-42.
3. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496-509.
4. Szabo SK, Hammerberg C, Yoshida Y, Bata-csorgo Z, Cooper KD. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 1998;111:1072-8.
5. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993;101:701-5.
6. Res PCM, Piskin G, de Boer OJ et al. Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS ONE 2010;5:e14108.
7. Hegyi Z, Zwicker S, Bureik D et al. Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine-Induced Proinflammatory S100 "Alarmins" Psoriasin (S100A7) and Koebnerisin (S100A15) in Psoriasis. J Invest Dermatol 2012;132:1416-24.
8. El-Moaty Zaher HA, El-Komy MHM, Hegazy RA, Mohamed El Khashab HA, Ahmed HH. Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients. J Am Acad Dermatol 2013;69:840-2.
9. Kryczek I, Bruce AT, Gudjonsson JE et al. Induction of IL-17 + T cell trafficking and development by IFN-γ: mechanism and pathological relevance in psoriasis. J. Immunol 2008;181:4733-41.
10. Papp KA, Leonardi C, Menter A et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012;366:1181-9.
11. Leonardi C, Matheson R, Zachariae C et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012;366:1190-9.
12. Eyerich S, Eyerich K, Pennino D et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009;119:3573-85.
13. Fujita H. The role of IL-22 and Th22 cells in human skin diseases. J Dermatol Sci 2013;72:3-8.
14. Spits H, Artis D, Colonna M et al. Innate lymphoid cells [mdash] a proposal for uniform nomenclature. Nat Rev Immunol 2013;13:145-9.
15. Dyring-Andersen B, Geisler C, Aggerbeck C et al. Increased number and frequency of group 3 innate lymphoid cells in non-lesional psoriatic skin. Br J Dermatol 2014;170:609-616.
16. Teunissen MBM, Munneke JM, Bernink JH et al. Composition of innate lymphoid cell (ILC) subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014;134:2351-60.
17. Villanova F, Flutter B, Tosi I et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44 + ILC3 in psoriasis. J Invest Dermatol 2014;134:984-91.
18. Pillai S, Bikle DD, Elias PM. 1, 25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988;263:5390-5.
19. 3 in human skin and the physiologic consequences. Science 1980;210:203-5.
20. Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin D receptor and T cell function. Front Immunol 2013;4:148.
21. Haussler MR, Whitfield GK, Kaneko I et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int 2013;92:77-98.
22. van der Vleuten CJ, de Jong EM, van de Kerkhof PC. Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 1996;288:366-72.
23. Kvist PH, Svensson L, Hagberg O, Hoffmann V, Kemp K, Røpke MA. Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model. J Transl Med 2009;7:107.
24. Reichrath J, Muller SM, Kerber A, Baum HP, Bahmer FA. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin. J Am Acad Dermatol 1997;36:19-28.
25. Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol 2004;13:106-12.
26. Lemire JM. lmmunomodulatory Role of 1, 25-Dihydroxyvitamin D3. J Cell Biochem 1992; 31: 26-31.
27. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pità O, Girolomoni G. Human CD25 + regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol 2003;171:5760-8.
28. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-γ and TNF-α. J. Immunol 1999;162:494-502.
29. Dyring-Andersen B, Skov L, Lovendorf MB et al. CD4(+) T cells producing interleukin (IL)-17, IL-22 and interferon-gamma are major effector T cells in nickel allergy. Contact Dermatitis 2013;68:339-47.
30. Wolk K, Haugen HS, Xu W et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 2009;87:523-36.
31. Moniaga CS, Egawa G, Miyachi Y, Kabashima K. Calcipotriol modulates IL-22 receptor expression and keratinocyte proliferation in IL-22-induced epidermal hyperplasia. J Dermatol Sci 2013;71:76-7.
32. de Jong EM, van der Kerkhof PC. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations. Br J Dermatol 1991;124:221-9.
33. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003;17:2386-92.
34. Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol 2011;23:519-28.
35. Joshi S, Pantalena L-C, Liu XK et al. 1, 25-dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011;31:3653-69.
36. Ikeda U, Wakita D, Ohkuri T et al. 1α, 25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 2010;134:7-16.
37. Agak GW, Qin M, Nobe J et al. Propionibacterium acnes induces an IL-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol 2013;134:1-8.
38. Peric M, Koglin S, Kim S et al. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol 2008;181:8504-12.
39. Dombrowski Y, Peric M, Koglin S et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 2011;3:82ra38.
40. Lande R, Gregorio J, Facchinetti V et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007;449:564-9.
41. Sakabe J-I, Umayahara T, Hiroike M, Shimauchi T, Ito T, Tokura Y. Calcipotriol Increases hCAP18 mRNA expression but inhibits extracellular LL37 peptide production in IL-17/IL-22-stimulated normal human epidermal keratinocytes. Acta Derm Venereol 2014;94:512-6.
42. Takahashi H, Ibe M, Kinouchi M, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Similarly potent action of 1, 25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003;31:21-8.